NasdaqGS - Delayed Quote • USD
Bolt Biotherapeutics, Inc. (BOLT)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 7:22 PM EDT
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 5 | 5 | 5 | 5 |
Avg. Estimate | -0.51 | -0.48 | -1.65 | -1.09 |
Low Estimate | -0.57 | -0.59 | -1.96 | -1.72 |
High Estimate | -0.47 | -0.28 | -1.22 | -0.25 |
Year Ago EPS | -0.45 | -0.48 | -1.83 | -1.65 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 4 | 4 | 5 | 4 |
Avg. Estimate | 2.06M | 1.93M | 7.16M | 4.56M |
Low Estimate | 1.5M | 1.2M | -- | -- |
High Estimate | 2.8M | 3.1M | 12.52M | 11.11M |
Year Ago Sales | 1.83M | 1.43M | 7.88M | 7.16M |
Sales Growth (year/est) | 12.80% | 34.70% | -9.10% | -36.30% |
Earnings History
CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
---|---|---|---|---|
EPS Est. | -0.51 | -0.49 | -0.5 | -0.48 |
EPS Actual | -0.45 | -0.48 | -0.43 | -0.47 |
Difference | 0.06 | 0.01 | 0.07 | 0.01 |
Surprise % | 11.80% | 2.00% | 14.00% | 2.10% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | -0.51 | -0.48 | -1.65 | -1.09 |
7 Days Ago | -0.51 | -0.48 | -1.65 | -1.09 |
30 Days Ago | -0.49 | -0.45 | -1.74 | -1.32 |
60 Days Ago | -0.52 | -0.28 | -1.64 | -1.33 |
90 Days Ago | -0.52 | -0.28 | -1.63 | -1.31 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | 1 | 1 |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
CURRENCY IN USD | BOLT | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | -13.30% | -- | -- | 6.50% |
Next Qtr. | 0.00% | -- | -- | 12.00% |
Current Year | 9.80% | -- | -- | 5.30% |
Next Year | 33.90% | -- | -- | 13.10% |
Next 5 Years (per annum) | -- | -- | -- | 11.09% |
Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
Maintains | HC Wainwright & Co.: Buy to Buy | 3/22/2024 |
Reiterates | HC Wainwright & Co.: Buy to Buy | 8/8/2023 |
Reiterates | HC Wainwright & Co.: Buy | 8/3/2023 |
Reiterates | HC Wainwright & Co.: Buy to Buy | 6/5/2023 |
Reiterates | HC Wainwright & Co.: Buy | 5/26/2023 |
Upgrade | SVB Leerink: Market Perform to Outperform | 5/12/2023 |
Related Tickers
ACHL Achilles Therapeutics plc
0.7600
-2.69%
NXTC NextCure, Inc.
1.3500
+4.65%
CMPX Compass Therapeutics, Inc.
1.4500
-2.03%
LVTX LAVA Therapeutics N.V.
2.7300
+3.41%
SNSE Sensei Biotherapeutics, Inc.
1.0200
-1.92%
MDNAF Medicenna Therapeutics Corp.
1.8200
+30.00%
MRUS Merus N.V.
45.04
+0.24%
LXEO Lexeo Therapeutics, Inc.
12.50
+2.80%
IPSC Century Therapeutics, Inc.
2.8800
-8.57%
HOWL Werewolf Therapeutics, Inc.
6.75
+8.70%